BioSyent Inc. (OTCMKTS:BIOYF) Sees Large Drop in Short Interest

BioSyent Inc. (OTCMKTS:BIOYF) was the target of a significant decline in short interest in February. As of February 28th, there was short interest totalling 1,300 shares, a decline of 23.5% from the February 13th total of 1,700 shares. Based on an average daily trading volume, of 1,200 shares, the days-to-cover ratio is presently 1.1 days.

BioSyent Trading Up 0.1 %

Shares of OTCMKTS BIOYF opened at $7.84 on Wednesday. BioSyent has a 12 month low of $5.93 and a 12 month high of $8.90. The company has a 50-day simple moving average of $7.70 and a 200-day simple moving average of $7.89.

BioSyent Increases Dividend

The company also recently declared a dividend, which was paid on Friday, March 14th. Stockholders of record on Monday, March 3rd were issued a dividend of $0.0347 per share. The ex-dividend date of this dividend was Friday, February 28th. This is an increase from BioSyent’s previous dividend of $0.03. This represents a dividend yield of 1.77%.

BioSyent Company Profile

BioSyent Inc, together with its subsidiaries, acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally. Its products include FeraMAX Pd Therapeutic 150 for the treatment of iron deficiency anemia; FeraMAX Pd Maintenance 45, a chewable supplement for the prevention of iron deficiency anemia; and FeraMAX Pd Powder 15, a powder form product used for preventing iron deficiency and iron deficiency anemia.